Zelira Lands In Germany With Distribution Agreement For Cannabinoid Sleep Medication
Australia-based Zelira Therapeutics Ltd. (OTCQB: ZLDAF), a company developing cannabinoid-based medicines, announced that it is entering the German market via a 5-year exclusive distribution agreement with IM Cannabis Corp. (CSE: IMCC) (NASDAQ:
